Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Acknowledgments
  • References
  • Version history
  • Article usage
  • Citations to this article (22)

Advertisement

Letter to the Editor Free access | 10.1172/JCI10910

Gelatinase B deficiency impairs reproduction

B. Dubois,1 B. Arnold,2 and G. Opdenakker1

1Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium2Laboratory for Molecular Immunology, German Cancer Research Centre, Heidelberg, Germany

Address correspondence to: G. Opdenakker, Rega Institute for Medical Research, University of Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: 32-16-337385; Fax: 32-16-337340; E-mail: Ghislain.Opdenakker@rega.kuleuven.ac.be.

Find articles by Dubois, B. in: JCI | PubMed | Google Scholar

1Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium2Laboratory for Molecular Immunology, German Cancer Research Centre, Heidelberg, Germany

Address correspondence to: G. Opdenakker, Rega Institute for Medical Research, University of Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: 32-16-337385; Fax: 32-16-337340; E-mail: Ghislain.Opdenakker@rega.kuleuven.ac.be.

Find articles by Arnold, B. in: JCI | PubMed | Google Scholar

1Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium2Laboratory for Molecular Immunology, German Cancer Research Centre, Heidelberg, Germany

Address correspondence to: G. Opdenakker, Rega Institute for Medical Research, University of Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: 32-16-337385; Fax: 32-16-337340; E-mail: Ghislain.Opdenakker@rega.kuleuven.ac.be.

Find articles by Opdenakker, G. in: JCI | PubMed | Google Scholar

Published September 1, 2000 - More info

Published in Volume 106, Issue 5 on September 1, 2000
J Clin Invest. 2000;106(5):627–628. https://doi.org/10.1172/JCI10910.
© 2000 The American Society for Clinical Investigation
Published September 1, 2000 - Version history
View PDF

Gelatinase B has been suggested to intervene at different stages of the cyclical changes in female reproduction (1–3): in the menstrual cycle, ovulation, implantation, parturition, and involution of the mammary glands after lactation. Gelatinase B has also been implicated in the process of growth and development of the embryo (4, 5). So far, the only reported spontaneous phenotype of gelatinase B deficiency is a delayed ossification of the growth plate in long bones (6). Most other phenotypes of gelatinase B are induced tissue reactions of the skin (7), the lung (8), the central nervous system or bone (9), and the aortic wall (10). Is there any spontaneous effect of gelatinase B ablation on reproductive capacity?

Gelatinase B–deficient mice were generated by a functional knockout of the active and zinc-binding domain of MMP-9 as previously described (9). In the three reports published to date (6, 9, 11), which described structurally distinct null alleles in the gene, gelatinase B–deficient mice were found to reproduce. However, in the course of studying the induction of autoimmune diseases in these animals, we noted a significantly diminished breeding efficiency of the gelatinase B–deficient mice as compared with wild-type controls.

During a test period of 3 months, the number of mice born per breeding pair is significantly lower in the gelatinase B–deficient than in the wild-type mice. In addition, the individual litters in knockout mice are smaller, and the percentage of infertile breeding pairs is elevated in the gelatinase B–deficient mice, whereas maximal litter numbers were observed in the wild-type mice (Table 1). The percentages of breeding pairs with 0, 1, 2, or 3 litters were respectively 18, 5, 18, and 59 for the wild-type mice (n = 39), versus 36, 20, 17, and 27 for the gelatinase B–deficient mice (n = 89) (P = 0.007, χ2 with Yates’s correction = 12.10, 4 × 2 contingency table, 3 degrees of freedom). Control and knockout mice were bred on C57BL/6 background. We observed a quantitatively similar suppression of fertility in gelatinase B–deficient mating pairs whether we compared MMP-9–/– animals with their wild-type littermates or with wild-type breeding pairs that carried the pure C57BL/6 background genotype. Hence, the differences seen in fertility are not caused by genetic background effects but, indeed, by gelatinase B deficiency. Further studies are required to elucidate whether this spontaneous phenotype may be attributed to male or to female fertility.

Table 1

Gelatinase B deficiency impairs fertility in mice

Matings of heterozygous mice resulted in the expected mendelian frequency of MMP-9+/+ (101/359, 28.1%), MMP-9–/– (81/359, 22.6%) and MMP-9+/– (177/359, 49.3%) mice (9), suggesting that embryonic and fetal development of homozygous mutant mice were not impaired, as also observed by Vu et al. (6).

Based on the combination of a reduced breeding efficiency of homozygous gelatinase B–deficient mice and the occurrence of the expected mendelian frequency of MMP-9+/+, MMP-9–/–, and MMP-9+/– mice in heterozygous matings, we conclude that decreased fertility is a spontaneous phenotype of gelatinase B deficiency. This finding reinforces the role of gelatinase B in the establishment and maintenance of a normal pregnancy and suggests that influencing gelatinase B activity may be a target in birth control. In addition, decreased fertility is anticipated in the treatment with nonselective and selective MMP-inhibitory drugs that are currently used in clinical trials for inflammatory and neoplastic diseases.

Acknowledgments

B. Dubois is a research assistant of the Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek–Vlaanderen [FWO-Vlaanderen]). This work was supported by the Charcot Foundation, Fortis FB Insurances, and the FWO-Vlaanderen in Belgium, and by the Deutsche Forschungsgemeinschaft (grants SFB 405 and EU BIO4-CT-96007) and the Volkswagen Foundation (grant I/72-422) in Germany. The authors thank Jan Mertens and Marcel Huybrechts for excellent animal care in the specific pathogen–free facility and J. Van Damme for critical reading of the manuscript.

References
  1. Jeziorska, M, Nagase, H, Salamonsen, LA, Woolley, DE. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil 1996. 107:43-51.
    View this article via: PubMed Google Scholar
  2. Librach, CL, et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991. 113:437-449.
    View this article via: PubMed CrossRef Google Scholar
  3. Vadillo-Ortega, F, et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995. 146:148-156.
    View this article via: PubMed Google Scholar
  4. Canete, SR, Gui, YH, Linask, KK, Muschel, RJ. Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos. Dev Dyn 1995. 204:30-40.
    View this article via: PubMed Google Scholar
  5. Oh, LYS, et al. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 1999. 19:8464-8475.
    View this article via: PubMed Google Scholar
  6. Vu, TH, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998. 93:411-422.
    View this article via: PubMed CrossRef Google Scholar
  7. Liu, Z, et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 1998. 188:475-482.
    View this article via: PubMed CrossRef Google Scholar
  8. Wang, M, et al. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci USA 1999. 96:6885-6889.
    View this article via: PubMed CrossRef Google Scholar
  9. Dubois, B, et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 1999. 104:1507-1515.
    View this article via: JCI PubMed CrossRef Google Scholar
  10. Pyo, R, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000. 105:1641-1649.
    View this article via: JCI PubMed CrossRef Google Scholar
  11. Itoh, T, et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 1999. 17:177-181.
    View this article via: PubMed CrossRef Google Scholar
Version history
  • Version 1 (September 1, 2000): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (22)

Go to

  • Top
  • Acknowledgments
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts